Related Experiment Videos
[Dextromethorphan maintains the function of the detached retina]
1Department of Ophthalmology, Iwate Medical University School of Medicine, Japan.
Nippon Ganka Gakkai Zasshi
|October 1, 1995
Summary
Dextromethorphan (DEX) protects the detached retina from ischemic damage. This N-methyl-D-aspartate receptor antagonist reduced retinal damage in rabbit eyes, suggesting therapeutic potential for retinal detachment.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Context:
- Retinal detachment (RD) can lead to significant vision loss due to ischemia.
- N-methyl-D-aspartate (NMDA) receptors play a role in excitotoxicity and neuronal damage.
- Dextromethorphan (DEX) is an NMDA receptor antagonist with potential neuroprotective properties.
Purpose:
- To investigate the neuroprotective effect of dextromethorphan (DEX) on ischemic damage in detached retinas.
- To evaluate the impact of DEX administration via subretinal injection and topical application on retinal function after induced detachment.
Summary:
- Transretinal electroretinograms (TR-ERGs) were recorded in rabbit eyes in vitro to assess retinal function after induced detachment.
- In experiment 1, DEX injected into the subretinal space preserved b-wave amplitude compared to controls.
- In experiment 2, topical DEX application also significantly reduced the decrease in b-wave amplitude following retinal detachment.
Impact:
- Dextromethorphan demonstrates potential to mitigate ischemic damage in detached retinas.
- These findings suggest DEX could be a therapeutic agent for preserving retinal function in detachment scenarios.
- Further research may explore DEX's clinical utility in managing retinal detachment complications.